This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tamehiro, N.
Right arrow Articles by Ochi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tamehiro, N.
Right arrow Articles by Ochi, K.
Agricola
Right arrow Articles by Tamehiro, N.
Right arrow Articles by Ochi, K.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, November 2003, p. 6412-6417, Vol. 69, No. 11
0099-2240/03/$08.00+0     DOI: 10.1128/AEM.69.11.6412-6417.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Innovative Approach for Improvement of an Antibiotic-Overproducing Industrial Strain of Streptomyces albus

Norimasa Tamehiro,1 Takeshi Hosaka,1 Jun Xu,1 Haifeng Hu,1 Noboru Otake,2 and Kozo Ochi1*

National Food Research Institute, Tsukuba, Ibaraki 305-8042, Japan,1 Tianjin Institute for Biomedicinal Research, Huayuan Industrial District, Tianjin, People’s Republic of China 3003842

Received 10 April 2003/ Accepted 16 August 2003

Working with a Streptomyces albus strain that had previously been bred to produce industrial amounts (10 mg/ml) of salinomycin, we demonstrated the efficacy of introducing drug resistance-producing mutations for further strain improvement. Mutants with enhanced salinomycin production were detected at a high incidence (7 to 12%) among spontaneous isolates resistant to streptomycin (Strr), gentamicin, or rifampin (Rifr). Finally, we successfully demonstrated improvement of the salinomycin productivity of the industrial strain by 2.3-fold by introducing a triple mutation. The Strr mutant was shown to have a point mutation within the rpsL gene (encoding ribosomal protein S12). Likewise, the Rifr mutant possessed a mutation in the rpoB gene (encoding the RNA polymerase ß subunit). Increased productivity of salinomycin in the Strr mutant (containing the K88R mutation in the S12 protein) may be a result of an aberrant protein synthesis mechanism. This aberration may manifest itself as enhanced translation activity in stationary-phase cells, as we have observed with the poly(U)-directed cell-free translation system. The K88R mutant ribosome was characterized by increased 70S complex stability in low Mg2+ concentrations. We conclude that this aberrant protein synthesis ability in the Strr mutant, which is a result of increased stability of the 70S complex, is responsible for the remarkable salinomycin production enhancement obtained.


* Corresponding author. Mailing address: National Food Research Institute, 2-1-12 Kannondai, Tsukuba, Ibaraki 305-8042, Japan. Phone: 81-29-838-8125. Fax: 81-29-838-7996. E-mail: kochi{at}affrc.go.jp.


Applied and Environmental Microbiology, November 2003, p. 6412-6417, Vol. 69, No. 11
0099-2240/03/$08.00+0     DOI: 10.1128/AEM.69.11.6412-6417.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Tanaka, Y., Komatsu, M., Okamoto, S., Tokuyama, S., Kaji, A., Ikeda, H., Ochi, K. (2009). Antibiotic Overproduction by rpsL and rsmG Mutants of Various Actinomycetes. Appl. Environ. Microbiol. 75: 4919-4922 [Abstract] [Full Text]  
  • Kim, J.-Y., Inaoka, T., Hirooka, K., Matsuoka, H., Murata, M., Ohki, R., Adachi, Y., Fujita, Y., Ochi, K. (2009). Identification and Characterization of a Novel Multidrug Resistance Operon, mdtRP (yusOP), of Bacillus subtilis. J. Bacteriol. 191: 3273-3281 [Abstract] [Full Text]  
  • Wang, G., Inaoka, T., Okamoto, S., Ochi, K. (2009). A Novel Insertion Mutation in Streptomyces coelicolor Ribosomal S12 Protein Results in Paromomycin Resistance and Antibiotic Overproduction. Antimicrob. Agents Chemother. 53: 1019-1026 [Abstract] [Full Text]  
  • Tala, A., Wang, G., Zemanova, M., Okamoto, S., Ochi, K., Alifano, P. (2009). Activation of Dormant Bacterial Genes by Nonomuraea sp. Strain ATCC 39727 Mutant-Type RNA Polymerase. J. Bacteriol. 191: 805-814 [Abstract] [Full Text]  
  • Wang, G., Hosaka, T., Ochi, K. (2008). Dramatic Activation of Antibiotic Production in Streptomyces coelicolor by Cumulative Drug Resistance Mutations. Appl. Environ. Microbiol. 74: 2834-2840 [Abstract] [Full Text]  
  • Nishimura, K., Hosaka, T., Tokuyama, S., Okamoto, S., Ochi, K. (2007). Mutations in rsmG, Encoding a 16S rRNA Methyltransferase, Result in Low-Level Streptomycin Resistance and Antibiotic Overproduction in Streptomyces coelicolor A3(2). J. Bacteriol. 189: 3876-3883 [Abstract] [Full Text]  
  • Kurosawa, K., Hosaka, T., Tamehiro, N., Inaoka, T., Ochi, K. (2006). Improvement of {alpha}-Amylase Production by Modulation of Ribosomal Component Protein S12 in Bacillus subtilis 168. Appl. Environ. Microbiol. 72: 71-77 [Abstract] [Full Text]